Popular Press from December 26, 2018
advertisement
- Novartis, China’s Gan & Lee push into insulin amid diabetes epidemic.
- MCG researchers say most important work still ahead for Type I diabetes.
- The doctor will see you now — and you, and you, and you.
- How Novant Health CEO Carl Armato’s Type 1 diabetes changed the lives of more than 6,000 patients.
- Insulin cost: Taking my own advice and taking it personally.
- Beta Bionics Wins Readers’ Choice for Medtech Company of the Year.